Pharmaceutical Lawsuit and Recall Information
At RxRecall.com, our pharmaceutical litigation and defective drug lawyers are committed to serving personal injury victims and are well versed in the product liability laws that protect consumers.
Alex Gorsky, Johnson and Johnson’s chief executive officer, ran the unit responsible for making Risperdal and is said to have “Intimate knowledge of the company’s illegal marketing efforts targeting doctors who treat troubled youths.” Risperdal is an antipsychotic medication which allegedly causes male children and youths to grow breast tissue. Mr. Gorsky ,who in February, was [...]
Risperdal was improperly marketed by Johnson & Johnson Johnson & Johnson settles a lawsuit over claims that it’s anti-psychotic drug “Risperdal” caused a male plaintiff to grow breast tissue. Janssen, a unit of Johnson & Johnson, faces 420 lawsuits brought against the company alleging personal injuries caused by Risperdal. Almost 130 of the 420 lawsuits [...]
Janssen Pharmaceuticals Inc. and parent company Johnson & Johnson reached a $181 million settlement with 36 states and the District of Columbia over charges of marketing Risperdal, Risperdal Consta, Risperdal M-Tab and Invega for non-FDA approved uses Risperdal, is a drug used to treat schizophrenia among other mental illnesses. Janssen is accused of [...]
Did Johnson & Johnson’s directors ignore wrongdoing? Johnson & Johnson was sued by investors in 2010 regarding the company’s marketing practices for Risperdal and for the production miscues that led to recalls of products such as children’s Tylenol. As part of a settlement of claims filed against Johnson & Johnson’s directors in federal court in Trenton, [...]
Johnson & Johnson announced this week that the company has reached an agreement with federal prosecutors to settle a misdemeanor criminal charge over its marketing practices for the antipsychotic drug, Risperdal. The agreement in principle on the criminal charge is “pursuant to a single misdemeanor violation of the Food, Drug and Cosmetic Act,” and includes [...]
Following reports of a musty odor, Ortho-McNeil-Janssen Pharmaceuticals, a Johnson and Johnson company, issued a recall of its Risperdal and risperidone medications. The drugs, which are used to treat schizophrenia and other forms of psychosis, are the newest additions to the growing list of various products that have been recalled by J&J and its subsidiaries. [...]
Johnson & Johnson’s Ortho-McNeil-Janssen Pharmaceuticals unit was recently ordered by a South Carolina judge to pay more than $327 million in penalties relating to deceptive marketing practices for its drug, Risperdal. According to the 17-page ruling from Judge Roger Couch in Spartanburg, S.C., J&J’s executives “allowed the profit-at-all-costs mentality to cloud” their judgment regarding the [...]
